Alessia Ciancio

9PUBLICATIONS
67CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Major global burdens of diseaseToxicology (incl. clinical toxicology)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir-Velpatasvir.

|Feb 26, 2025
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Luca Rinaldi, Mauro Viganò, Alessia Ciancio

|Oct 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration.

Valerio Rosato, Riccardo Nevola, Marcello Dallio

|Jan 21, 2023
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study.

Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino

|Jan 21, 2023
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.

Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina

|Dec 11, 2022
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project.

Claudio Borghi, Alessia Ciancio, Ivan Gentile

Pageof 2

Frequent Collaborators

4 joint publications

Gian Paolo Caviglia

3 joint publications

Giorgio Maria Saracco

2 joint publications

Angelo Armandi

2 joint publications

Paolo Gallo